DE60307308D1 - 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel - Google Patents

4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel

Info

Publication number
DE60307308D1
DE60307308D1 DE60307308T DE60307308T DE60307308D1 DE 60307308 D1 DE60307308 D1 DE 60307308D1 DE 60307308 T DE60307308 T DE 60307308T DE 60307308 T DE60307308 T DE 60307308T DE 60307308 D1 DE60307308 D1 DE 60307308D1
Authority
DE
Germany
Prior art keywords
derivatives
aminopiperidin
medicaments
preparing
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60307308T
Other languages
English (en)
Other versions
DE60307308T2 (de
Inventor
Yves Lamberty
Christophe Genicot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Application granted granted Critical
Publication of DE60307308D1 publication Critical patent/DE60307308D1/de
Publication of DE60307308T2 publication Critical patent/DE60307308T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE60307308T 2002-10-04 2003-09-30 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel Expired - Lifetime DE60307308T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02022191 2002-10-04
EP02022191 2002-10-04
PCT/EP2003/010824 WO2004030668A1 (en) 2002-10-04 2003-09-30 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments

Publications (2)

Publication Number Publication Date
DE60307308D1 true DE60307308D1 (de) 2006-09-14
DE60307308T2 DE60307308T2 (de) 2006-12-28

Family

ID=32049973

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60307308T Expired - Lifetime DE60307308T2 (de) 2002-10-04 2003-09-30 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel

Country Status (21)

Country Link
US (1) US7488741B2 (de)
EP (2) EP1693061A1 (de)
JP (1) JP2006513151A (de)
KR (1) KR20050055748A (de)
CN (1) CN1688307A (de)
AT (1) ATE334680T1 (de)
AU (1) AU2003270291A1 (de)
BR (1) BR0314811A (de)
CA (1) CA2500664A1 (de)
DE (1) DE60307308T2 (de)
DK (1) DK1556045T3 (de)
ES (1) ES2268406T3 (de)
MX (1) MXPA05003290A (de)
NO (1) NO20052172L (de)
NZ (1) NZ539015A (de)
PL (1) PL376368A1 (de)
PT (1) PT1556045E (de)
RU (1) RU2005110409A (de)
SI (1) SI1556045T1 (de)
WO (1) WO2004030668A1 (de)
ZA (1) ZA200502330B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052858A2 (en) * 2002-12-06 2004-06-24 Eli Lilly And Company Inhibitors of monoamine uptake
EP1638934B1 (de) 2003-06-11 2008-01-09 Eli Lilly And Company 3-amino-pyrrolidine als inhibitoren der monoamin-wiederaufnahme
WO2005053663A2 (en) * 2003-11-24 2005-06-16 Eli Lilly And Company Norepinephrine reuptake inhibitors useful for treatment of cognitive failure
WO2005118531A1 (en) * 2004-06-01 2005-12-15 Eli Lilly And Company Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake
EP2968359B1 (de) 2013-03-12 2021-01-20 Celltaxis, LLC Verfahren zur hemmung einer leukotrien-a4-hydrolase
KR20150127245A (ko) 2013-03-14 2015-11-16 켈탁시스, 인코퍼레이티드 류코트라이엔 a4 가수분해효소의 저해제
WO2019232306A1 (en) 2018-05-31 2019-12-05 Celtaxsys, Inc. Method of reducing pulmonary exacerbations in respiratory disease patients
CN111233751B (zh) * 2020-03-25 2021-02-02 丽水绿氟科技有限公司 一种3,3-二氟-4-氨基哌啶类化合物及其衍生物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG12406A (en) * 1976-08-12 1979-03-31 Janssen Pharmaceutica Nv Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPH05148234A (ja) * 1991-10-02 1993-06-15 Hokuriku Seiyaku Co Ltd アルカン酸誘導体
DE4404183A1 (de) * 1994-02-10 1995-08-17 Merck Patent Gmbh 4-Amino-1-piperidylbenzoylguanidine
GB0108876D0 (en) * 2001-04-09 2001-05-30 Novartis Ag Organic Compounds

Also Published As

Publication number Publication date
CN1688307A (zh) 2005-10-26
EP1693061A1 (de) 2006-08-23
AU2003270291A1 (en) 2004-04-23
NO20052172L (no) 2005-06-30
US7488741B2 (en) 2009-02-10
MXPA05003290A (es) 2005-07-05
BR0314811A (pt) 2005-08-02
EP1556045A1 (de) 2005-07-27
EP1556045B1 (de) 2006-08-02
JP2006513151A (ja) 2006-04-20
SI1556045T1 (sl) 2007-02-28
NO20052172D0 (no) 2005-05-03
PT1556045E (pt) 2006-12-29
CA2500664A1 (en) 2004-04-15
KR20050055748A (ko) 2005-06-13
PL376368A1 (en) 2005-12-27
RU2005110409A (ru) 2005-09-10
NZ539015A (en) 2006-02-24
ZA200502330B (en) 2006-05-31
ATE334680T1 (de) 2006-08-15
ES2268406T3 (es) 2007-03-16
DE60307308T2 (de) 2006-12-28
US20060128753A1 (en) 2006-06-15
WO2004030668A1 (en) 2004-04-15
DK1556045T3 (da) 2006-11-27

Similar Documents

Publication Publication Date Title
ATE108453T1 (de) Benzopyridopiperidin, -piperidyliden und - piperazin-verbindungen, zusammensetzungen, methoden zur herstellung und verwendung.
EA200602191A1 (ru) 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
WO2005018557A3 (en) Substituted pyridinones
BR0009007A (pt) Derivados de piperidina, tetraidropiridina epiperazina; composto; composição farmacêutica;utilização e método
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
WO2004087677A3 (en) Pyrimidin-4-one derivatives and their use as p38 kinase modulators
EA200600294A1 (ru) [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении
BR0310106A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica
WO2006034833A1 (en) Cyclic diarly ureas suitable as tyrosine kinase inhibitors
EP2062898A3 (de) Spirocyclische Cyclohexan-Derivate
WO2005080345A3 (en) Imidazoline derivatives having cb1-antagonistic activity
NO20052172D0 (no) 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter
NO20071967L (no) Imidazo-benzodiazepinderivater
ATE401304T1 (de) Kationisch substituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DE502006004182D1 (de) Substituierte 5,6,7,8-tetrahydro-imidazoä1 ,2-aüpyridin-2-ylamin-verbindungen und deren verwendung zur herstellung von arzneimitteln
CA2498291A1 (en) Diazabicyclic compounds useful in the treatment of cns and other disorders
DE60221283D1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
ATE367380T1 (de) Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate
ATE247645T1 (de) Neue piperazinylalkylthiopyrimidine derivate, diese enthaltende pharmazeutische zusammenstellungen und verfahren zu deren herstellung
ATE401327T1 (de) Pyrroloimidazolderivate ,verfahern zu ihrer herstellung, diese enthaltende zusammensetzungen, und ihre verwendung als nootropika
DE602004021358D1 (de) Benzosulfonamide derivate, deren verfahren zum herstellung, und deren verwendung zur behandlung von schmerzen
DE50311923D1 (de) Harnstoff- und urethan-substituierte acylharnstoffe, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE397584T1 (de) N-alkylierte gaba verbindungen, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE417831T1 (de) Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel
ATE421961T1 (de) Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: UCB PHARMA, S.A., BRUXELLES, BE